TC-410

N/A

Report date: 2024/11/21 15:14:19

Base Information

Drug NameTC-410
Drug Alias NameTC-410
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionMesothelin modulatorsMucin-16 modulators
TargetsMesothelinMucin-16
Therapy Area/IndicationsOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTcr2 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTcr2 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A